Viewing Study NCT04447651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-01-02 @ 11:30 PM
Study NCT ID: NCT04447651
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-14
First Post: 2020-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Solid Tumor View
None SF3B1 Gene Mutation View
None Spliceosome Mutation View
None U2AF1 Gene Mutation View
None SRSF2 Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None sequencing View
None metastatic solid tumor View
None spliceosome mutation View
None immune checkpoint inhibition View
None immunotherapy View